Jason Iliffe – Trademark Portfolio

Entity Type: 01

Jason Iliffe holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CL IQ. The owner is based in London.

Hobart Building 2 Wards Place

Flat 2602

London E149XJ , GB

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CL IQ
CL IQ
Registered 2025
CLIQ
CLIQ
Abandoned 2024

Trademark Classifications

Jason Iliffe's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Jason Iliffe have?

Jason Iliffe has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Jason Iliffe file in?

Jason Iliffe files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Jason Iliffe's most well-known trademarks?

Jason Iliffe's registered trademark portfolio includes well-known marks such as CL IQ. These are among 1 currently registered trademark in the portfolio.

What is Jason Iliffe's trademark registration success rate?

Jason Iliffe has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.